Tuberculosis treatment success rate in Burkina Faso
Burkina Faso: Tuberculosis treatment success rate was 81.0% in 2023. ▲ Rising
Tuberculosis treatment success rate in Burkina Faso, 1995–2023
Source: WHO (2025) – with minor processing by Our World in Data. Measured in %.
Analysis
Burkina Faso recorded 81.0% for tuberculosis treatment success rate in 2023.
That represents a change of down 1.2% on the previous year and up 1.2% over ten years.
Over the whole period, tuberculosis treatment success rate in Burkina Faso peaked at 82.0% in 2020 and was at its lowest, 25.0%, in 1995.
That places Burkina Faso 121st out of 206 countries with data for 2023, putting it in the middle of the range.
The long-run direction has been consistently rising across the 29 years of available data.
Tuberculosis treatment success rate in Burkina Faso, year by year
| Year | % | Change |
|---|---|---|
| 1995 | 25.0% | — |
| 1996 | 29.0% | +16.0% |
| 1997 | 61.0% | +110.3% |
| 1998 | 59.0% | -3.3% |
| 1999 | 61.0% | +3.4% |
| 2000 | 60.0% | -1.6% |
| 2001 | 65.0% | +8.3% |
| 2002 | 64.0% | -1.5% |
| 2003 | 66.0% | +3.1% |
| 2004 | 67.0% | +1.5% |
| 2005 | 71.0% | +6.0% |
| 2006 | 72.0% | +1.4% |
| 2007 | 73.0% | +1.4% |
| 2008 | 76.0% | +4.1% |
| 2009 | 77.0% | +1.3% |
| 2010 | 78.0% | +1.3% |
| 2011 | 77.0% | -1.3% |
| 2012 | 80.0% | +3.9% |
| 2013 | 80.0% | +0.0% |
| 2014 | 81.0% | +1.2% |
| 2015 | 78.0% | -3.7% |
| 2016 | 80.0% | +2.6% |
| 2017 | 80.0% | +0.0% |
| 2018 | 80.0% | +0.0% |
| 2019 | 81.0% | +1.2% |
| 2020 | 82.0% | +1.2% |
| 2021 | 82.0% | +0.0% |
| 2022 | 82.0% | +0.0% |
| 2023 | 81.0% | -1.2% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 47.0% | 25.0% | 61.0% | 5 |
| 2000s | 69.1% | 60.0% | 77.0% | 10 |
| 2010s | 79.5% | 77.0% | 81.0% | 10 |
| 2020s | 81.8% | 81.0% | 82.0% | 4 |
Countries ranked near Burkina Faso
- 121 Dominican Republic 81.0% compare
- 121 Puerto Rico 81.0% compare
- 121 Türkiye 81.0% compare
More health data for Burkina Faso
- Un projection of annual infant deaths, annual growth rate -1.67 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.8925 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,142 deaths per 1,000 people (2090)
- Number of infants who die before age 1 13,085 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 4 (2025)
- Population ages 00-04, female, annual growth rate 0.8681 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0693 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.7133 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0.0001 units per US$ of GDP (2025)
Frequently asked questions
- What is tuberculosis treatment success rate in Burkina Faso?
- Tuberculosis treatment success rate in Burkina Faso was 81.0% in 2023, according to WHO (2025) – with minor processing by Our World in Data.
- What is the highest tuberculosis treatment success rate recorded in Burkina Faso?
- The highest recorded value was 82.0% in 2020.
- What is the lowest tuberculosis treatment success rate recorded in Burkina Faso?
- The lowest recorded value was 25.0% in 1995.
- How does Burkina Faso rank for tuberculosis treatment success rate?
- Burkina Faso ranks 121st out of 206 countries with data for 2023.
- Is tuberculosis treatment success rate rising or falling in Burkina Faso?
- Over the last ten years it is up 1.2%. The long-run trend across the full record is rising.
- Where does this Burkina Faso data come from?
- The figures come from WHO (2025) – with minor processing by Our World in Data, published as part of Tuberculosis treatment success rate. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 29 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Treatment success rate among new and relapse cases.